Andros Pharmaceuticals Co., Ltd.(TW:6917)
NT$31.00+1.35 (+4.55%)
TW:6917
Andros Pharmaceuticals Co., Ltd. Revenue
NT$31.00
At close:+1.35 (+4.55%)
Andros Pharmaceuticals Co., Ltd. (6917) Revenue
Andros Pharmaceuticals Co., Ltd. Revenue
Andros Pharmaceuticals Co., Ltd. had a revenue of 5.84M in the quarter ending Jun 30, 2026, with 6.42%. This bring the company's revenue in the last twelve months to 11.32M, Increased 106.42%. In the fiscal year ending Dec 31, 2025, Andros Pharmaceuticals Co., Ltd. had annual revenue of 5.55M with 2633.00% growth.
- Revenue (ttm)
- 11.32M
- Revenue Growth
- 5765.28%
- P/S Ratio
- 308.84
- Revenue/Employee
- TWD 369,867
- Employees
- 15
- Market Cap
- TWD 1.71B
Revenue Chart
Andros Pharmaceuticals Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.55M | 5.34M | 2633.00% |
| Dec 31, 2024 | 203.00K | -602.00K | -74.78% |
| Dec 31, 2023 | 805.00K | -908.00K | -53.01% |
| Dec 31, 2022 | 1.71M | -11.60M | -87.13% |
| Dec 31, 2021 | 13.31M | 10.04M | 307.37% |
| Dec 31, 2020 | 3.27M | 3.27M | ― |
| Dec 31, 2019 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.